Nothing Special   »   [go: up one dir, main page]

NL6501301A - - Google Patents

Info

Publication number
NL6501301A
NL6501301A NL6501301A NL6501301A NL6501301A NL 6501301 A NL6501301 A NL 6501301A NL 6501301 A NL6501301 A NL 6501301A NL 6501301 A NL6501301 A NL 6501301A NL 6501301 A NL6501301 A NL 6501301A
Authority
NL
Netherlands
Application number
NL6501301A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6501301A publication Critical patent/NL6501301A/xx
Priority claimed from US509217A external-priority patent/US3410850A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NL6501301A 1964-04-03 1965-02-02 NL6501301A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35725664A 1964-04-03 1964-04-03
US50916365A 1965-11-22 1965-11-22
US509217A US3410850A (en) 1962-10-30 1965-11-22 4h-pyrazino-[2, 3d][1, 3]oxazin-4-ones and their preparation

Publications (1)

Publication Number Publication Date
NL6501301A true NL6501301A (ru) 1965-10-04

Family

ID=27408296

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6501301A NL6501301A (ru) 1964-04-03 1965-02-02

Country Status (2)

Country Link
US (1) US3491094A (ru)
NL (1) NL6501301A (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140776A (en) * 1977-09-16 1979-02-20 Merck & Co., Inc. N-pyrazinecarbonyl-N'-acylguanidines
US4604394A (en) * 1984-10-01 1986-08-05 Merck & Co., Inc. Antiarrhythmic compositions and method
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US7745442B2 (en) * 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
CN105073717B (zh) 2012-12-17 2018-05-22 帕里昂科学公司 可用于治疗由黏膜水化不足造成的疾病的氯-吡嗪甲酰胺衍生物
AU2013363215B2 (en) 2012-12-17 2018-03-01 Parion Sciences, Inc. 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE639393A (ru) * 1962-10-30
US3274191A (en) * 1963-11-15 1966-09-20 Merck & Co Inc N-(3-aminopyrazinoyl) benzamidines and process for preparing

Also Published As

Publication number Publication date
US3491094A (en) 1970-01-20

Similar Documents

Publication Publication Date Title
BE659858A (ru)
BE642588A (ru)
BE626684A (ru)
BE642114A (ru)
BE642104A (ru)
BE637950A (ru)
BE637777A (ru)
BE623398A (ru)
BE637333A (ru)
BE636791A (ru)
BE632875A (ru)
BE629793A (ru)
BE628611A (ru)
BE627931A (ru)
BE627390A (ru)
BE627057A (ru)
BE642243A (ru)
BE642316A (ru)
BE622126A (ru)
BE661083A (ru)
BE621510A (ru)
BE613833A (ru)
BE610935A (ru)
BE661081A (ru)
BE660244A (ru)